Comparison of the therapeutic effect of native and preconditioned human umbilical cord-derived multipotent mesenchymal stromal cells on a rat model of acute pancreatitis

Home/2023, Vol. 11, No. 2/Comparison of the therapeutic effect of native and preconditioned human umbilical cord-derived multipotent mesenchymal stromal cells on a rat model of acute pancreatitis

Cell and Organ Transplantology. 2023; 11(2):104-113.
DOI: 10.22494/cot.v11i2.156

Comparison of the therapeutic effect of native and preconditioned human umbilical cord-derived multipotent mesenchymal stromal cells on a rat model of acute pancreatitis

Pikus P.1,2, Rymar S.1,2, Pustovalov A.3, Shuvalova N.2, Reshetnyk Ye.3, Kordium V.1,2

  • 1Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv, Ukraine
  • 2Institute of Genetic and Regenerative Medicine, M. D. Strazhesko National Scientific Center of Cardiology, Clinical and Regenerative Medicine, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • 3Educational and Scientific Center “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine

Abstract

Pancreatitis is a disease defined by an acute or chronic inflammatory process of the pancreas, which is induced by the activation of trypsin inside acinocytes. The consequences of these processes are necrosis of the parenchyma of the organ, abscess and systemic complications, which lead to patient mortality, which reaches 30-47 %. To date, there is no effective treatment for acute pancreatitis in the world. Potential candidates for the treatment of this disease can be multipotent mesenchymal stromal/stem cells (MMSCs) due to their immunomodulatory properties.
The purpose of the study was to compare the therapeutic effect of transplantation of native human umbilical cord-derived MMSCs (hUC-MMSCs) and hUC-MMSCs preconditioned with H2O2 in a rat model of acute pancreatitis.
Methods. Acute pancreatitis in rats was induced by intraperitoneal injection of L-arginine at a dose of 3.5 g/kg body weight twice at an interval of 1 hour. Rats were divided into four groups: group 1 – negative control, animals received 0.9 % saline, group 2 – positive control (pancreatitis). 3 days after the emergence of the signs of developed acute pancreatitis, part of group 2 was divided into groups 3 and 4. The group 3 rats were intraperitoneally transplanted with native hUC-MMSCs at a dose of 1.5×106 cells/kg, and the group 4 were injected with the same dose of hUC-MMSCs, preconditioned with H2O2 at a concentration of 30 µmol for 18 hours. The effect of native or preconditioned hUC-MMSCs was evaluated 3, 7 and 14 days after their administration. The results of the study were evaluated according to the α-amylase index, the identification of insulin in the pancreatic islets, and the histological study.
Results. It was shown that 3 days after the administration of L-arginine, the level of α-amylase increased 5 times compared to the negative control, the level of glucose in the blood increased 2.5 times, which indicates damage to both the exocrine and endocrine parts of the pancreas. On microscopic examination, fibrosis of the pancreatic parenchyma was observed, which increased 3.5 times compared to the negative control. 3 days after the transplantation of native hUC-MMSCs, the level of α-amylase in the blood decreased by 1.7 times, and in the variant with preconditioned hUC-MMSCs – by 2 times compared to the group 2. After 7 days, the α-amylase index in the group with native hUC-MMSCs decreased by 2.4 times compared to the positive control in the group with preconditioned hUC-MMSCs and was almost within the norm. After 7 days, a gradual recovery of the architecture of the pancreas was observed, but in the group with preconditioned hUC-MMSCs, the recovery of the organ occurred faster. Histological sections revealed the replacement of anucleated areas with acinocytes, which was evidenced by a 3-fold decrease in the number of anucleated cells in the variant with native hUC-MMSCs, while in the variant with preconditioned hUC-MMSCs the indicator was almost normal. In both variants, a positive histochemical PAS-reaction was observed for the identification of insulin in the pancreatic islets, and blood glucose levels corresponded to the norm. After 14 days, complete recovery of the pancreas was in both variants.
Conclusion. The results of the study showed that the transplantation of hUC-MMSCs in rats with acute pancreatitis leads to the restoration of the architecture of the pancreas parenchyma and its functioning, and the administration of hUC-MMSCs preconditioned with H2O2 significantly improves the therapeutic effect and accelerates the recovery of the pancreas.

Keywords: acute pancreatitis; human umbilical cord-derived multipotent mesenchymal stromal cells; stem cell preconditioning; cell transplantation


Full Text PDF

1. Shah AU, Sarwar A, Orabi AI, Gautam, et al. Protease activation during in vivo pancreatitis is dependent on calcineurin activation. J Physiol Gastrointest Liver Physiol. 2009; 297:67-73.
https://doi.org/10.1152/ajpgi.00181.2009
PMid:20501444 PMCid:PMC2777459
2. Petrov MS, Shanbhag S, Chakraborty M, Phillips A, et al. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. J Gastroenterol. 2010; (3):13-820.
https://doi.org/10.1053/j.gastro.2010.06.010
PMid:20540942
3. Forsmark CE, Baillie J. AGA Institute technical review on acute pancreatitis. Rev Gastroenterol Méx. 2007; 72(3):257-285.
https://doi.org/10.1053/j.gastro.2007.03.065
PMid:17484894
4. Iannuzzi J, James A, Leong J, Quan J, et al. Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis. J. Gastroenterology. 2022; 162(1):122-134.
https://doi.org/10.1053/j.gastro.2021.09.043
PMid:34571026
5. Weiss FU, Laemmerhirt F, Lerch MM. Etiology and Risk Factors of Acute and Chronic Pancreatitis. Visc Med. 2019; 35(2):73-81.
https://doi.org/10.1159/000499138
PMid:31192240 PMCid:PMC6514487
6. Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med. 2016; 375:1972-1981. Available from:
https://doi.org/10.1056/NEJMra1505202
PMid:27959604
7. Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015; 386: 85-96. Available from:
https://doi.org/10.1016/S0140-6736(14)60649-8
PMid:25616312
8. Szatmary P, Grammatikopoulos T, Cai W, Huang W, et al. Acute Pancreatitis: Diagnosis and Treatment. J Springer link. 2022; 82:1251-1276.
https://doi.org/10.1007/s40265-022-01766-4
PMid:36074322 PMCid:PMC9454414
9. Wang CY, Zhao YP. The guidelines interpretation for diagnosis and treatment of severe acute pancreatitis. Zhonghua Wai Ke Za Zhi. 2013; 51(3):198-200.
10. Zhilong M, Zhou J, Yang T, Xie W. Mesenchymal stromal cell therapy for pancreatitis: Progress and challenges. Med Res Rev. 2021; 41(4):2474-2488.
https://doi.org/10.1002/med.21801
PMid:33840113
11. Kawakubo K, Ohnishi S, Kuwatani M, Sakamoto N. Mesenchymal stem cell therapy for acute and chronic pancreatitis. J Gastroenterol. 2018; 53:1-5.
https://doi.org/10.1007/s00535-017-1363-9
PMid:28646417
12. Munir F, Jamshed MB, Shahid N, Muhammad SA, et al. Current status of diagnosis and Mesenchymal stem cells therapy for acute pancreatitis. Physiol Rep. 2019; 7(21):e14170.
https://doi.org/10.14814/phy2.14170
PMid:31691545 PMCid:PMC6832003
13. Hu C, Li L. Preconditioning influences mesenchymal stem cell properties in vitro and in vivo. J Cell Mol Med. 2018; 22(3):1428-1442.
https://doi.org/10.1111/jcmm.13492
PMid:29392844 PMCid:PMC5824372
14. Lopes-Pacheco M, Rocco PR. Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases. Front. Pharmacol. 2023; 14:1-23.
https://doi.org/10.3389/fphar.2023.1067422
PMid:37007034 PMCid:PMC10062457
15. Liu P, Xie X, Wu H, Li H, et al. Conditioned medium of mesenchymal stem cells pretreated with H2O2 promotes intestinal mucosal repair in acute experimental colitis. Sci Rep. 2022; 12(1):20772.
https://doi.org/10.1038/s41598-022-24493-y
PMid:36456585 PMCid:PMC9715703
16. Zhang J, Chen G, Wang J, Zhao J, et al. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton’s Jelly mesenchymal stem cells after myocardial infarction. Chin Med J. 2012; 125(19):3472-8.
17. Garrido-Pascual P, Alonso-Varona A, Castro B, Burón M, et al. H2O2-preconditioned human adipose-derived stem cells (HC016) increase their resistance to oxidative stress by overexpressing Nrf2 and bioenergetic adaptation. Stem Cell Res Ther. 2020; 11(335):14.
https://doi.org/10.1186/s13287-020-01851-z
PMid:32746890 PMCid:PMC7397657
18. Seshareddy K, Troyer D, Weiss ML. Method to isolate mesenchymal-like cells from Wharton’s Jelly of umbilical cord. Methods Cell Biol. 2008; 86:101-119.
https://doi.org/10.1016/S0091-679X(08)00006-X
PMid:18442646
19. European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes. European Treaty Series. Strasbourg, 18.III.1986; 123.
https://doi.org/rm.coe.int/168007a67b
20. Suvarna SK, Layton C, Bancroft JD. Bancroft’s theory and practice of histological techniques. 7th ed. Churchill Livingstone Elsevier. 2015.
https://doi.org/10.1016/C2015-0-00143-5
21. Mikhailova VS. Methods of histological staining. BioVitrum С. 2009; 1-66.  https://www.studfile.net/preview/2279283/
22. Denis G, Baskin A. Historical Perspective on the Identification of Cell Types in Pancreatic Islets of Langerhans by Staining and Histochemical Techniques. J Histochem Cytochem. 2015; 63(8):543-558.
https://doi.org/10.1369/0022155415589119
PMid:26216133 PMCid:PMC4530402
23. Crook M. Hyperamylasaemia: don’t forget undiagnosed carcinoma. Ann Clin Biochem. 2014; 51(1):5-7.
https://doi.org/10.1177/0004563213510490
PMid:24194585
24. Matull JR, Pereira SP, O’Donohue JW. Biochemical markers of acute pancreatitis. Journal of Clinical Pathology. 2006; 59(4):340-344.
https://doi.org/10.1136/jcp.2002.002923
PMid:16567468 PMCid:PMC1860356
25. Kishino Y, Kawamura S. Pancreatic damage induced by injecting a large dose of arginine.Virchows Arch B Cell Pathol Incl Mol Pathol. 1984; 47:147-155.
https://doi.org/10.1007/BF02890197
PMid:6151295
26. Ye J, Scallet A, Carp K. Abnormal periodic acid-Schiff (PAS)-positive substance in the islets of Langerhans, pituitaries and adrenal glands of 139H scrapie-infected hamsters. J. Histopathol. 1999; 14:673-678.  https://doi.org/10.14670/HH-14.673
27. González AM, Garcia T, Samper E, et al. Assessment of the protective effects of oral tocotrienols in arginine chronic-like pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2011; 301(5):846-855.
https://doi.org/10.1152/ajpgi.00485.2010
PMid:21852363
28. Meng HB, Gong J, Zhou B, Hua J, Yao L, Song ZS. Therapeutic effect of human umbilical cord‐derived mesenchymal stem cells in rat severe acute pancreatitis. Int J Clin Exp Pathol. 2013; 6(12):2703‐2712.
29. Ma Z, Song G, Zhao D, et al. Bone marrow‐derived mesenchymal stromal cells ameliorate severe acute pancreatitis in rats via hemeoxygenase‐1‐mediated anti‐oxidant and anti‐inflammatory effects. Cytotherapy. 2018; 21(2):162‐174.
https://doi.org/10.1016/j.jcyt.2018.11.013
PMid:30600195
30. Hua J, He ZG, Qian DH, et al. Angiopoietin-1 gene-modified human mesenchymal stem cells promote angiogenesis and reduce acute pancreatitis in rats. Int J Clin Exp Pathol. 2014; 7(7):3580-3595.
31. Qian D, Gong J, He Z, et al. Bone marrow‐derived mesenchymal stem cells repair necrotic pancreatic tissue and promote angiogenesis by secreting cellular growth factors involved in the SDF‐1α/CXCR4 axis in rats. Stem Cells Int. 2015; 1‐20.
https://doi.org/10.1155/2015/306836
PMid:25810724 PMCid:PMC4355908
32. Sara M, Mahmoud M, Nehal I, Mohamed M. Abdel-Daim S, et al. Mesenchymal Stromal Cell Therapy for Pancreatitis: A Systematic Review. Oxid Med Cell Longev. 2018; 3250864.
https://doi.org/10.1155/2018/3250864
PMid:29743979 PMCid:PMC5878867
33. Chan LK, Tsesmelis M, Gerstenlauer M, Leithäuser F, et al. Functional IKK/NF-κB signaling in pancreatic stellate cells is essential to prevent autoimmune pancreatitis. Communications Biology. 2022; 5:509.
https://doi.org/10.1038/s42003-022-03371-3
PMid:35624133 PMCid:PMC9142538
34. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014; 37:81-90.
https://doi.org/10.2337/dc14-S081
PMid:24357215
35. Albai O, Roman D, Frandes M. Hypertriglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus. Ther Clin Risk Manag. 2017; 13:515-522.
https://doi.org/10.2147/TCRM.S134560
PMid:28450786 PMCid:PMC5399973
36. Zhao H, He Z, Huang D, Gao J, et al. Infusion of Bone Marrow Mesenchymal Stem Cells Attenuates Experimental Severe Acute Pancreatitis in rats. Stem Cells Int. 2016; 2016: 7174319.
https://doi.org/10.1155/2016/7174319
PMid:27721836 PMCid:PMC5046031
37. Scuteri A, Monfrini M. Mesenchymal Stem Cells as New Therapeutic Approach for Diabetes and Pancreatic Disorders. Int J Mol Sci. 2018; 19(9):2783.
https://doi.org/10.3390/ijms19092783
PMid:30223606 PMCid:PMC6163453
38. Ezquer F, Ezquer M, Contador D, Ricca M, et al. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. Stem Cells. 2012; 30:1664-1674.
https://doi.org/10.1002/stem.1132
PMid:22644660
39. Chen J, Liu Z, Hong M, Zhang H, Chen C, et al. Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells. PLoS ONE. 2014; 9:e115316.
https://doi.org/10.1371/journal.pone.0115316
PMid:25514634 PMCid:PMC4267846

Pikus P, Rymar S, Pustovalov A, Shuvalova N, Reshetnyk Ye, Kordium V. Comparison of the therapeutic effect of native and preconditioned human umbilical cord-derived multipotent mesenchymal stromal cells on a rat model of acute pancreatitis. Cell Organ Transpl. 2023; 11(2):104-113. Available from: https://doi.org/10.22494/cot.v11i2.156

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.